Trial of Pulsed Electric Field Therapy in Patients With Late-stage Non-small Cell Lung Cancer

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 6, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions

NSCLC

Interventions

DEVICE

PEF

PEF device treated in the trial.

DRUG

Anti-PD-1 monoclonal antibody

Anti-PD-1 monoclonal antibody administered on Day 7 then routinely.

Trial Locations (1)

RECRUITING

The first Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors

lead

Energenx Medical LTD.

INDUSTRY